Search Results

Instylla’s Embrace Hydrogel Embolic System Launched 

January 28, 2026—Instylla, Inc., a developer of resorbable embolics for peripheral vascular embolization, announced the completion of the first commercial procedure using the company’s Embrace hydrogel embolic system (HES).

Thrombolex Bashir Catheters Evaluated in RESCUE Trial for Treating Acute Intermediate-Risk PE

January 17, 2022—Thrombolex, Inc. announced positive results from the prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the pivotal RESCUE trial, which is being conducted under an FDA investigational device exemption (IDE).

Microbot’s Liberty Robotic System Pivotal Trial Expanded to Second Site

July 16, 2024—Microbot Medical recently announced that Baptist Hospital of Miami in Miami, Florida, completed its first clinical procedure with the company’s Liberty endovascular robotic surgical system in the pivotal trial of the device.

First Cancer Radioembolization Procedures Performed With Hansen Medical's Magellan Robotic System

June 3, 2015—Hansen Medical, Inc. announced the completion of the first robotically assisted radioembolization procedures for cancer treatment using the company’s Magellan robotic system, which has been used extensively for interventional transarterial chemoembolization.

Sirtex Medical’s SIR-Spheres FlexDose Select Delivery Program Launched for Colorectal Cancer

August 5, 2024—Sirtex Medical announced the launch of its SIR-Spheres FlexDose Select delivery program to offer yttrium-90 (Y90) selective internal radiation therapy for the treatment of metastatic colorectal cancer.

First Cases Performed With Okami Medical’s LOBO-3 Vascular Occluder After FDA Clearance

March 5, 2020—Okami Medical Inc. announced the successful completion of the first cases with the company’s LOBO-3 vascular occlusion system, which recently received FDA 510(k) clearance for the occlusion of peripheral arteries.

FDA Clears Hansen Medical's Magellan Robotic Catheter eKit

February 2, 2016—Hansen Medical, Inc. announced it has received US Food and Drug Administration clearance for the Magellan robotic catheter eKit (MRC eKit), which extends robotic capabilities and control throughout procedures in the peripheral vasculature.

Thrombolex Presents Final Results From RESCUE Trial of Bashir Catheter

September 17, 2022—Thrombolex, Inc. announced that the final results of its RESCUE trial demonstrated that pharmacomechanical catheter-directed thrombolysis (CDT) therapy using the company's Bashir endovascular catheter led to a significant improvement in right ventricular function with an excellent safety profile.